Pelvic actinomycosis presenting with a large abscess and bowel stenosis with marked response to conservative treatment: a case report
© Nozawa et al; licensee BioMed Central Ltd. 2007
Received: 22 May 2007
Accepted: 21 November 2007
Published: 21 November 2007
Pelvic actinomycosis is a rare disease that can result in abscess formation, bowel obstruction, and other serious complications. Moreover, the correct diagnosis can seldom be established before radical surgery because the disease often mimics pelvic neoplasms. It has been recently recognized that pelvic actinomycosis is associated with long-term use of an intrauterine contraceptive device.
We report a woman with a long-standing intrauterine contraceptive device who visited our hospital complaining of symptoms mimicking large bowel ileus with a subacute course. X-ray fluorography and sigmoidoscopy showed marked stenosis in the sigmoid colon but rejected the possibility of colon cancers. Abdomino-pelvic CT and MRI revealed a huge abscess lying over the urinary bladder and anterior to the uterus. Furthermore, a cervical Papanicolaou smear disclosed Actinomyces species. We removed the intrauterine device from the patient. Subsequent high-dose ampicillin administration led to dramatic shrinkage of the abscess and improved the management of the bowel movement quickly. This is a successful case of symptomatic pelvic actinomycosis that was correctly diagnosed and treated without unnecessary surgical intervention.
A 51-year-old woman, gravida 2, para 2, visited a local clinic and presented with constipation, worsening abdominal cramps, nausea and increased abdominal girth for a month. She was initially diagnosed with enterocolitis, but became progressively more constipated. Two weeks later, she was referred to our hospital for further examinations, having received fosfomycin for the previous 4 days aimed at alleviating her elevated white blood cell (WBC) count (12,700/μl) with a raised C-reactive protein (CRP) level of 11.3 mg/dl.
The patient was admitted to the hospital to assess the cause of bowel obstructive symptoms and to treat malnutrition. Her body weight had decreased by 7 kg over a month compared to when in a healthy condition (40 kg). Physical examination on admission revealed tenderness in the lower abdomen with tympanic bowel sounds but no palpable mass. Her body temperature was 37.0°C. Laboratory tests revealed leucocytosis of 12,000/μl with a left shift (Seg 87%), mild anemia (hemoglobin: 11.9 mg/dl), CRP level of 6.99 mg/dl and erythrocyte sedimentation rate (ESR) of 70.0 mm/h. Serum tumor markers were all normal: carcinoembryonic antigen was 1.4 ng/ml, CA19-9 12.6 U/ml, and CA-125 28.4 U/ml. Moreover, no abnormal findings were seen in liver and renal function tests.
Based on the radiological images and cytopathological result, we envisaged that her symptoms were primarily caused by pelvic Actinomyces infection associated with the long-standing IUD. Eight days after admission, the IUD was removed, while intravenous administration of ampicillin (4 g/day) was initiated.
Her recovery was quite good; WBC count and CRP returned to normal levels in a week by antibiotic treatment. With the help of a mild laxative, her abdominal distension and tenderness gradually ameliorated. Soon she was capable of eating as much as previously and was discharged on hospital day 18. The patient was switched to oral ampicillin for a month. Repeated MRI showed that the pelvic abscess had mostly disappeared.
Actinomyces is a slow-growing, filamentous, gram-positive anaerobe. Traditionally actinomycosis of the female genital tract has been thought to originate from ascending infection of the bacteria by oro- or anogenital contact or by a pessary. The association between IUDs and pelvic actinomycosis was first described around 1970 [1, 2], and has now been well documented [3–5]. Overgrowth of Actinomyces together with alteration of the genital tract environment and/or breached uterine mucosal barrier by mechanical means may develop endometritis and pelvic actinomycosis.
Fiorino reviewed 92 cases of pelvic actinomycosis. The patients were usually in their reproductive years with a history of having an IUD for 8 years on average. Multiple symptoms can appear in varied frequencies, such as abdominal pain (85%), body weight loss (44%), fever (60%), and vaginal discharge (24%). On laboratory tests, 70% of the patients were anemic, 76% had leucocytosis, and 95% had accelerated ESR . Because most of the aforementioned abnormalities were observed on admission, our patient was a typical case of pelvic actinomycosis. Notably, IUD implantation had continued for 21 years, a very long duration that is thought to have a higher risk of developing pelvic actinomycosis .
The usual CT findings of pelvic actinomycosis include abscess, an infiltrative mass with dense and non-homogenous contrast enhancement, and bowel wall thickness [5–7]. By contrast, there have been only a few reports on MRI findings of pelvic actinomycosis [6, 8], describing that Actinomyces-associated masses were of intermediate signal intensity on T1-weighted images and of intermediate to low signal intensity on T2-weighted sequences, whereas cystic components exhibited a high T2 signal [6, 8]. Unlike mass-forming actinomycosis, we observed that the wall of abscess-forming actinomycosis was of intermediate to high signal intensity on T2-weighted MR images.
Unfortunately, these image findings of actinomycosis appear non-specific  and are dependent on the involved regions and degree of inflammation . Together with the clinical symptoms, the images often simulate those of gastrointestinal and gynecological malignancies [3, 4]. These reasons render the disease undiagnosable, and 83% of cases undergo major surgical operation such as hysterectomy, salpingo-oophoerectomy, bowel resection, drainage of abscess, etc [3, 7]. Hence, the most crucial stage of this uncommon disease is to make a correct diagnosis. In this regard, Gupta et al. underscored the importance of cervical Papanicolaou smears, immunofluorescent staining and anaerobic culture in the diagnosis of actinomycosis . CT- or ultrasound-guided aspiration or needle biopsy may be useful to reach a diagnosis [4, 5]. In our case, causative colorectal neoplasm(s) were unlikely from the results of X-ray fluorography and sigmoidoscopy, and we rather suspected infection. The image findings in our patient were essentially in accordance with the features of pelvic actinomycosis but were not distinct from other inflammatory diseases. The most helpful evidence to confirm the diagnosis was typical aggregates of Actinomyces species detected in a cervical smear .
Once diagnosed, pelvic actinomycosis should be treated primarily by penicillin administration as well as IUD removal . Tetracycline, clindamycin and erythromycin can alternatively be used for patients allergic to penicillin . Even when a pelvic abscess is present, conservative medical treatment is considered the first-line therapy unless it is large, for instance, more than 8 cm in diameter, which often requires surgical drainage . Although our patient manifested severe gastrointestinal symptoms and an abscess close to 8 cm in diameter, we explored the opportunity to avoid unnecessary drainage. She responded to the conservative therapy rapidly and remarkably, which was confirmed by follow-up laboratory tests and MRI.
Currently, IUDs are one of the most common methods of reversible contraception worldwide . Although IUDs are highly effective for preventing unintended pregnancy, users and medical doctors should remember the risk of complications, including pelvic inflammatory disease . Deliberate examinations, careful evaluation of results and images, and a cooperative and appropriate treatment strategy spared our patient from radical interventions. Whenever examining IUD users with gastrointestinal symptoms, pelvic actinomycosis should be included in the differential diagnosis .
Written consent was obtained from the patient for the publication of the case report.
erythrocyte sedimentation rate
intrauterine contraceptive device
magnetic resonance imaging
white blood cell.
We thank Drs. Ryo Matsuoka, Kazunori Nagasaka (Department of Gynecology, Odaira Memorial Tokyo Hitachi Hospital) and Haruhiko Itoh (Department of Radiology, University of Tokyo) for discussion on the radiological images.
- Brenner RW, Gehring SWJ: Pelvic actinomycosis in the presence of an endocervical contraceptive device. Obstet Gynecol. 1967, 29: 71-73.PubMedGoogle Scholar
- Henderson SR: Pelvic actinomycosis associated with an intrauterine device. Obstet Gynecol. 1973, 41: 726-732.PubMedGoogle Scholar
- Fiorino AS: Intrauterine contraceptive device-associated actinomycotic abscess and Actinomyces detection on cervical smear. Obstet Gynecol. 1996, 87: 142-149. 10.1016/0029-7844(95)00350-9.View ArticlePubMedGoogle Scholar
- Lee YC, Min D, Holcomb K, Buhl A, DiMaio T, Abulafia O: Computed tomography guided core needle biopsy diagnosis of pelvic actinomycosis. Gynecol Oncol. 2000, 79: 318-323. 10.1006/gyno.2000.5994.View ArticlePubMedGoogle Scholar
- Lely RJ, van Es HW: Case 85: pelvic actinomycosis in association with an intrauterine device. Radiology. 2005, 236: 492-494. 10.1148/radiol.2362031034.View ArticlePubMedGoogle Scholar
- Hawnaur JM, Reynolds K, McGettingan C: Magnetic resonance imaging of actinomycosis presenting as pelvic malignancy. Br J Radiol. 1999, 72: 1006-1011.View ArticlePubMedGoogle Scholar
- Baird AS: Pelvic actinomycosis: still a cause for concern. J Fam Plann Reprod Health Care. 2005, 31: 73-74. 10.1783/0000000052973004.View ArticlePubMedGoogle Scholar
- Tou SIH, David G, Thomas EA, Schneider HJ: Unusual cause of a frozen pelvis. Gut. 2006, 55: 990,1011-10.1136/gut.2005.080960.View ArticlePubMedGoogle Scholar
- Gupta PK: Intrauterine contraceptive devices: vaginal cytology, pathologic changes and clinical implications. Acta Cytol. 1982, 26: 571-613.PubMedGoogle Scholar
- Peterson HB, Curtis KM: Clinical practice. Long-acting methods of contraception. N Engl J Med. 2005, 353: 2169-2175. 10.1056/NEJMcp044148.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.